Kernt M - Search Results

1

Intraocular caspofungin: in vitro safety profile for human ocular cells.

Kernt M, Kampik A. Kernt M, et al. Mycoses. 2011 Jul;54(4):e110-21. doi: 10.1111/j.1439-0507.2009.01853.x. Epub 2010 Feb 19. Mycoses. 2011. PMID: 20202116

2

[Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells].

Kernt M, Welge-Lüssen U, Yu A, Neubauer AS, Kampik A. Kernt M, et al. Ophthalmologe. 2007 Nov;104(11):965-71. doi: 10.1007/s00347-007-1569-y. Ophthalmologe. 2007. PMID: 17653724 German.

3

Intracameral voriconazole: in vitro safety for human ocular cells.

Kernt M, Kampik A. Kernt M, et al. Toxicology. 2009 Apr 28;258(2-3):84-93. doi: 10.1016/j.tox.2009.01.008. Epub 2009 Jan 19. Toxicology. 2009. PMID: 19428927

4

[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

Kernt M, Hirneiss C, Neubauer AS, Liegl RG, Eibl KH, Wolf A, de Kaspar H, Ulbig MW, Kampik A. Kernt M, et al. Ophthalmologe. 2010 Aug;107(8):720-7. doi: 10.1007/s00347-009-2027-9. Ophthalmologe. 2010. PMID: 19756636 German.

5

Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.

Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge CS, Wolf A, Ulbig MW, Kampik A. Kernt M, et al. Br J Ophthalmol. 2010 Nov;94(11):1533-9. doi: 10.1136/bjo.2010.182162. Br J Ophthalmol. 2010. PMID: 20962354 Free article.

6

[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].

Thiele S, Liegl RG, König S, Siedlecki J, Langer J, Eibl K, Haritoglou C, Kampik A, Kernt M. Thiele S, et al. Among authors: kernt m. Klin Monbl Augenheilkd. 2013 Mar;230(3):247-54. doi: 10.1055/s-0032-1328161. Epub 2013 Mar 18. Klin Monbl Augenheilkd. 2013. PMID: 23508753 German.

7

In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.

Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lüssen U. Kernt M, et al. J Cataract Refract Surg. 2008 Mar;34(3):480-8. doi: 10.1016/j.jcrs.2007.10.046. J Cataract Refract Surg. 2008. PMID: 18299076

8

Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.

Kernt M, Neubauer AS, De Kaspar HM, Kampik A. Kernt M, et al. Retina. 2009 Mar;29(3):362-70. doi: 10.1097/IAE.0b013e31818d4b9b. Retina. 2009. PMID: 18997637

9

Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression.

Kernt M, Neubauer AS, Liegl R, Eibl KH, Alge CS, Lackerbauer CA, Ulbig MW, Kampik A. Kernt M, et al. J Cataract Refract Surg. 2009 Feb;35(2):354-62. doi: 10.1016/j.jcrs.2008.10.052. J Cataract Refract Surg. 2009. PMID: 19185255

10

[Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium].

Kernt M, Hirneiss C, Neubauer AS, Lackerbauer CA, Eibl KH, Wolf A, Ulbig M, Kampik A. Kernt M, et al. Ophthalmologe. 2010 Feb;107(2):150-7. doi: 10.1007/s00347-009-1945-x. Ophthalmologe. 2010. PMID: 19499230 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters